CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
Amulez and sunlight +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03805737
NCT03805737N/ACompleted

Indoor Daylight Photo Dynamic Therapy (PDT) for Actinic Keratosis

Dartmouth-Hitchcock Medical Center·interventional·Posted Jan 16, 2019·Updated Jan 20, 2022

In Brief

A clinical study evaluating Amulez and sunlight and Amulez and red light treatment for Actinic Keratosis. Completed, enrolled 43 participants across 1 site.

Detailed Summary

The purpose of this study is to understand better if indoor daylight Photo Dynamic Therapy (PDT) can provide effective lesion clearing versus conventional red lamp light therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 16, 2019
Enrollment StartNov 1, 2019
Primary CompletionOct 6, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.5 years ago

Interventions

Amulez and sunlightother

Amulez and sun exposure for 2 hours

Amulez and red light treatmentother

Amulez and red light treatment for 10 minutes